By the 5th of March it was officially announced that Laboratorium Ofichem receives an approval for the “Certificate of Suitability” (CEP) request for Pamidronate Disodium Pentahydrate.
The approval for the EDQM specific related API registration procedure is a milestone in the Pamidronate project of Laboratorium Ofichem. After a lot of work, efforts and energy we are proud to be one of three companies world wide which received the certificate for the Pamidronate Disodium Pentahydrate.
This approval is an additional confirmation on the quality of our products and the quality and knowledge related to the company responsible for these products.
We will apply for more CEP’s with other products in the future and we are confident to get an approval for these products as well.